Viewing Study NCT03283202


Ignite Creation Date: 2025-12-25 @ 3:47 AM
Ignite Modification Date: 2026-02-01 @ 10:42 PM
Study NCT ID: NCT03283202
Status: COMPLETED
Last Update Posted: 2021-04-29
First Post: 2017-09-06
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Study of Safety and Efficacy of Avadomide (CC-122) Combined With RCHOP for Newly-diagnosed DLBCL With Poor Risk Factors
Sponsor: Celgene
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Diffuse B-Cell Lymphoma View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Diffuse B-Cell Lymphoma View
None R-CHOP-21 View
None International Prognostic Index (IPI) View